Solitary recurrence of IgG4-related giant coronary aneurysm: Case report and review of the literature focusing on treatment strategies and complications.

IF 0.9 Q4 RHEUMATOLOGY Modern rheumatology case reports Pub Date : 2023-12-29 DOI:10.1093/mrcr/rxad065
Hiroyuki Kawahara, Ichiro Mizushima, Yasushi Matsumoto, Kenji Sakata, Masayuki Takamura, Dai Inoue, Satomi Kasashima, Mitsuhiro Kawano
{"title":"Solitary recurrence of IgG4-related giant coronary aneurysm: Case report and review of the literature focusing on treatment strategies and complications.","authors":"Hiroyuki Kawahara, Ichiro Mizushima, Yasushi Matsumoto, Kenji Sakata, Masayuki Takamura, Dai Inoue, Satomi Kasashima, Mitsuhiro Kawano","doi":"10.1093/mrcr/rxad065","DOIUrl":null,"url":null,"abstract":"<p><p>Coronary periarteritis is a dangerous manifestation of IgG4-related disease, because it forms coronary artery aneurysms, which may cause sudden cardiac death. We report the case of a 78-year-old woman with IgG4-related coronary periarteritis and a coronary aneurysm, which showed progressive enlargement despite maintenance therapy for Type 1 autoimmune pancreatitis. This case was unique, in that coronary periarteritis was the only active lesion that recurred. Low-dose glucocorticoids suppressed the progression of periarterial lesions but led to rapid thinning of the aneurysmal wall and an increase in the size of mural thrombi, which pose a risk of myocardial infarction. Our systematic literature review including 98 cases of 86 articles was performed to examine its treatment strategies and complications. Among the cases in which the effect of immunosuppressive therapy could be followed radiologically, 33 of 37 (89.1%) cases showed improvement in wall thickening/periarterial soft tissue, while 6 of 13 (46.2%) showed worsening increase in the outer diameter of the coronary aneurysms. We propose a draft treatment algorithm and suggest that immunosuppressive therapy for IgG4-related coronary periarteritis with coronary aneurysms should be conducted only after the therapeutic benefit has been determined to outweigh the risks. Because coronary periarteritis can occur without other organ involvement, as in our case, all cases of IgG4-related disease require careful monitoring of coronary artery lesions.</p>","PeriodicalId":94146,"journal":{"name":"Modern rheumatology case reports","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern rheumatology case reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/mrcr/rxad065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Coronary periarteritis is a dangerous manifestation of IgG4-related disease, because it forms coronary artery aneurysms, which may cause sudden cardiac death. We report the case of a 78-year-old woman with IgG4-related coronary periarteritis and a coronary aneurysm, which showed progressive enlargement despite maintenance therapy for Type 1 autoimmune pancreatitis. This case was unique, in that coronary periarteritis was the only active lesion that recurred. Low-dose glucocorticoids suppressed the progression of periarterial lesions but led to rapid thinning of the aneurysmal wall and an increase in the size of mural thrombi, which pose a risk of myocardial infarction. Our systematic literature review including 98 cases of 86 articles was performed to examine its treatment strategies and complications. Among the cases in which the effect of immunosuppressive therapy could be followed radiologically, 33 of 37 (89.1%) cases showed improvement in wall thickening/periarterial soft tissue, while 6 of 13 (46.2%) showed worsening increase in the outer diameter of the coronary aneurysms. We propose a draft treatment algorithm and suggest that immunosuppressive therapy for IgG4-related coronary periarteritis with coronary aneurysms should be conducted only after the therapeutic benefit has been determined to outweigh the risks. Because coronary periarteritis can occur without other organ involvement, as in our case, all cases of IgG4-related disease require careful monitoring of coronary artery lesions.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
IgG4相关巨大冠状动脉瘤的孤立性复发:病例报告和文献综述,重点关注治疗策略和并发症。
冠状动脉周围炎是IgG4相关疾病的危险表现,因为它会形成冠状动脉瘤,可能导致心脏性猝死。我们报告了一例78岁的女性,她患有IgG4相关的冠状动脉周围炎和冠状动脉瘤,尽管对1型自身免疫性胰腺炎进行了维持治疗,但仍显示出进行性增大。该病例的独特之处在于,冠状动脉周围炎是唯一复发的活动性病变。低剂量的糖皮质激素抑制了动脉周围病变的进展,但会导致动脉瘤壁迅速变薄和壁血栓大小增加,这会带来心肌梗死的风险。我们对86篇文章中的98例进行了系统的文献回顾,以检查其治疗策略和并发症。在可以从放射学上观察免疫抑制治疗效果的病例中,37例中有33例(89.1%)显示壁增厚/动脉周围软组织改善,13例中有6例(46.2%)显示冠状动脉瘤外径增加恶化。我们提出了一个治疗算法草案,并建议只有在确定治疗益处大于风险后,才能对IgG4相关的冠状动脉周围炎伴冠状动脉瘤进行免疫抑制治疗。因为冠状动脉周围炎可以在没有其他器官受累的情况下发生,就像在我们的病例中一样,所有IgG4相关疾病的病例都需要仔细监测冠状动脉病变。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.40
自引率
0.00%
发文量
0
期刊最新文献
Symptomatic Pachydermodactyly: A Case Report. Mid-term outcomes of distal tibial oblique osteotomy in patients with rheumatoid arthritis: a report of three cases. Anaphylaxis and prolonged allergic reactions caused by intra-articular injection of diclofenac etalhyaluronate in knee osteoarthritis: A case report. Granulomatosis with polyangiitis with lacrimal gland enlargement and pancreatic swelling: case report and literature review. Isolated central nervous system lymphomatoid granulomatosis in an older adult patient with systematic lupus erythematosus: A case report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1